STXS News and Press, Stereotaxis Inc.

ST. LOUIS, May 29, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer in surgical robotics for minimally invasive endovascular intervention, today announces the successful treatment of the first heart rhythm patients by Penn Presbyterian Medical Center (PPMC) utilizing the advanced Gene...

2024-05-24 08:58:48 ET More on Stereotaxis Stereotaxis Makes A Strategic Acquisition Bolstering Its Future Major Regulatory Approvals Coming For Stereotaxis In The Next 10 Months Stereotaxis Q1 2024 Earnings Preview Seeking Alpha’s Quant Rating on Ster...

ST. LOUIS, May 24, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has received CE Mark recertification under the European Union’s new Medical Device Regulation...

2024-05-23 04:38:03 ET Summary Stereotaxis made a strategic acquisition of catheter company Access Point Technologies, which is expected to contribute $5 million in sales in the first 12 months after the acquisition. Access Point will help Stereotaxis release a robotically navigat...

ST. LOUIS, May 22, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer in surgical robotics for minimally invasive endovascular intervention, today announced that Hospital Santa Maria della Pietà, in Nola in the Metropolitan City of Naples, has established the first robotic cardiac ...

ST. LOUIS, May 15, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has been invited to present at HRS Africa Summit 2024, scheduled to take place during Heart Rhythm S...

2024-05-13 19:52:13 ET Stereotaxis, Inc. (STXS) Q1 2024 Earnings Conference Call May 13, 2024, 4:30 PM ET Company Participants David Fischel - Chairman and Chief Executive Officer Kimberly Peery - Chief Financial Officer Conference Call Participants Frank...

2024-05-13 16:16:10 ET More on Stereotaxis Major Regulatory Approvals Coming For Stereotaxis In The Next 10 Months Stereotaxis, Inc. (STXS) Q4 2023 Earnings Call Transcript Stereotaxis Q1 2024 Earnings Preview Seeking Alpha’s Quant Rating on Stereotaxi...

2024-05-13 16:05:59 ET More on Stereotaxis Major Regulatory Approvals Coming For Stereotaxis In The Next 10 Months Seeking Alpha’s Quant Rating on Stereotaxis Historical earnings data for Stereotaxis Read the full article on Seeking Alpha For f...

ST. LOUIS, May 13, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial results for the first quarter ended March 31, 2024. “Stereotaxis is driving continued ...